GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.
- Published in:
- Diabetes, 2024, v. 73, n. 10, p. 1605, doi. 10.2337/db23-0972
- By:
- Publication type:
- Article
Works by Patrício, Bárbara G.
Results: 3
1
2
Visceral Adipose Tissue Displays Unique Metabolomic Fingerprints in Obesity, Pre-Diabetes and Type 2 Diabetes.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5695, doi. 10.3390/ijms22115695
- By:
- Publication type:
- Article
3
Dysglycemia Shapes Visceral Adipose Tissue's Response to GIP, GLP-1 and Glucagon in Individuals with Obesity.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 5, p. 587, doi. 10.3390/metabo13050587
- By:
- Publication type:
- Article